This inventor holds 6 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignees: Crescendo Biologics Limited, Crescendo Biologies Limited. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: The Innovative Contributions of Mike Romanos
Introduction
Mike Romanos is a distinguished inventor based in Cambridge, GB, known for his significant contributions to the field of therapeutic molecules. With a total of six patents to his name, Romanos has made strides in developing innovative solutions for cancer treatment and other disorders.
Latest Patents
Among his latest patents, Romanos has developed binding molecules that specifically target prostate-specific membrane antigen (PSMA). This invention focuses on single human variable heavy chain domain antibodies and related methods for treating cancer. Additionally, he has created IL-17A binding proteins, which are useful in treating disorders such as psoriasis.
Career Highlights
Throughout his career, Mike Romanos has worked with notable companies, including Crescendo Biologics Limited and Crescendo Biologies Limited. His work in these organizations has allowed him to advance his research and contribute to the development of groundbreaking therapeutic solutions.
Collaborations
Romanos has collaborated with esteemed colleagues, including Brian Timothy McGuinness and Thomas Sandal, further enhancing the impact of his work in the field of biotechnology.
Conclusion
Mike Romanos exemplifies the spirit of innovation through his patents and contributions to medical science. His work continues to pave the way for advancements in treatment options for various disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile